RxDoctor Payments Data

Heather Jacene, MD

Nuclear Medicine · Boston, MANPI 1700922879

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,690 of the $7,727 with a category attached, or 99.5%. Advanced Accelerator Applications accounts for 74.1% of it on its own, with 1 other manufacturer making up the rest.

$7,727in general payments, 2019–2025

Across 4 payments — averaging $1931.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Advanced Accelerator Applications$6K
  • Blue Earth Diagnostics$2K
$649,487in research payments, 2019–2025

Across 56 payments — averaging $11,598 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Blue Earth Diagnostics$356K
  • E.r. Squibb & Sons, L.L.C.$170K
  • Progenics Pharmaceuticals, Inc.$87K
  • AstraZeneca$37K

What the payments were for

  • Consulting fees$7,690100%
  • Food & beverage$370%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear medicine providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$107,683
Medicare patients
975
Services billed
1,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →